Atossa Genetics (ATOS) Short Interest Ratio & Short Volume $1.18 +0.08 (+6.76%) As of 11:24 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atossa Genetics Short Interest DataAtossa Genetics (ATOS) has a short interest of 2.80 million shares. This marks a -21.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 859,310 shares to cover all short positions.Current Short Interest2,800,000 sharesPrevious Short Interest3,570,000 sharesChange Vs. Previous Month-21.57%Dollar Volume Sold Short$2.29 millionShort Interest Ratio2.6 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares129,170,000 sharesPercentage of Shares Shorted2.17%Today's Trading Volume2,705,920 sharesAverage Trading Volume859,310 sharesToday's Volume Vs. Average315% Short Selling Atossa Genetics? Sign up to receive the latest short interest report for Atossa Genetics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATOS Short Interest Over TimeATOS Days to Cover Over TimeATOS Percentage of Float Shorted Over Time Atossa Genetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20252,800,000 shares $2.29 million -21.6%N/A2.6 $0.82 8/31/20253,570,000 shares $2.72 million -2.5%3.0%3.3 $0.76 8/15/20253,660,000 shares $2.84 million -3.9%N/A3.3 $0.78 7/31/20253,810,000 shares $3.18 million -6.9%3.2%3.3 $0.83 7/15/20254,090,000 shares $3.74 million -12.4%N/A4.3 $0.91 6/30/20254,670,000 shares $3.88 million -37.1%3.9%4.9 $0.83 6/15/20257,420,000 shares $6.16 million -2.6%6.2%10.5 $0.83 5/31/20257,620,000 shares $5.98 million +6.7%6.6%11.1 $0.78 5/15/20257,140,000 shares $7.04 million +0.1%6.1%11 $0.99 4/30/20257,130,000 shares $6.40 million -6.6%N/A11.6 $0.90 Get the Latest News and Ratings for ATOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atossa Genetics and its competitors with MarketBeat's FREE daily newsletter. 4/15/20257,630,000 shares $4.76 million -5.8%6.6%12 $0.62 3/31/20258,100,000 shares $5.45 million -5.6%7.0%12 $0.67 3/15/20258,580,000 shares $6.18 million -3.2%7.4%12.3 $0.72 2/28/20258,860,000 shares $6.78 million -1.5%7.6%11.5 $0.77 2/15/20258,990,000 shares $7.46 million -2.8%7.7%10.9 $0.83 1/31/20259,250,000 shares $7.79 million +5.8%N/A10.6 $0.84 1/15/20258,740,000 shares $7.60 million +2.0%N/A10.6 $0.87 12/31/20248,570,000 shares $8.09 million +4.5%N/A11.3 $0.94 12/15/20248,200,000 shares $9.18 million -29.3%N/A11.6 $1.12 11/30/202411,600,000 shares $15.08 million -6.8%N/A18.5 $1.30 11/15/202412,450,000 shares $15.94 million -2.5%N/A20.5 $1.28 10/31/202412,770,000 shares $17.62 million -2.2%N/A24.4 $1.38 10/15/202413,050,000 shares $18.66 million +0.9%N/A24.1 $1.43 9/30/202412,930,000 shares $19.65 million -1.9%N/A20 $1.52 9/15/202413,180,000 shares $20.03 million +2.2%N/A13.2 $1.52 8/31/202412,900,000 shares $17.67 million +0.3%N/A12.8 $1.37 8/15/202412,860,000 shares $16.46 million +1.1%N/A12 $1.28 7/31/202412,720,000 shares $17.17 million +3.1%N/A10.4 $1.35 7/15/202412,340,000 shares $17.28 million +20.0%N/A9.3 $1.40 6/30/202410,280,000 shares $12.23 million -5.6%N/A6.8 $1.19 6/15/202410,890,000 shares $13.07 million -2.9%N/A6.4 $1.20 5/31/202411,220,000 shares $14.59 million -2.3%N/A5.9 $1.30 5/15/202411,480,000 shares $18.48 million +0.4%N/A6 $1.61 4/30/202411,440,000 shares $17.27 million -7.4%N/A6.4 $1.51 4/15/202412,350,000 shares $21.12 million +17.0%N/A7.6 $1.71 3/31/202410,560,000 shares $19.01 million +24.5%N/A7.7 $1.80 3/15/20248,480,000 shares $10.94 million +18.6%N/A9 $1.29 2/29/20247,150,000 shares $6.99 million +1.6%N/A13.6 $0.98 2/15/20247,040,000 shares $7.11 million +2.9%N/A16.8 $1.01 1/31/20246,840,000 shares $5.84 million -2.2%N/A17.4 $0.85 1/15/20246,990,000 shares $6.36 million +9.9%N/A18.4 $0.91 12/31/20236,360,000 shares $5.60 million +1.0%N/A16.7 $0.88 12/15/20236,300,000 shares $4.67 million +1.0%N/A19.3 $0.74 11/30/20236,240,000 shares $4.64 million -2.0%N/A19.3 $0.74 11/15/20236,370,000 shares $4.17 million -4.2%N/A17.4 $0.65 10/31/20236,650,000 shares $4.46 million -5.7%N/A16.4 $0.67 10/15/20237,050,000 shares $4.65 million -2.8%N/A16.3 $0.66 9/30/20237,250,000 shares $5.34 million -8.8%N/A13.1 $0.74 9/15/20237,950,000 shares $6.28 million -3.1%N/A9.7 $0.79 8/31/20238,200,000 shares $6.48 million -1.8%N/A9.6 $0.79 8/15/20238,350,000 shares $7.36 million -1.7%N/A8.6 $0.88 7/31/20238,490,000 shares $9.34 million -2.6%N/A9.1 $1.10 7/15/20238,720,000 shares $10.81 million +12.5%N/A9.5 $1.24 6/30/20237,750,000 shares $9.77 million +6.9%N/A9.8 $1.26 6/15/20237,250,000 shares $6.52 million -3.6%N/A14.4 $0.90 5/31/20237,520,000 shares $6.99 million -3.2%N/A16.1 $0.93 5/15/20237,770,000 shares $5.50 million -3.7%N/A22.4 $0.71 4/30/20238,070,000 shares $5.16 million -3.1%N/A24.9 $0.64 4/15/20238,330,000 shares $6.12 million -1.3%N/A24.4 $0.74 3/31/20238,440,000 shares $6.12 million -1.9%N/A19.4 $0.72 3/15/20238,600,000 shares $5.59 million +0.6%N/A17.1 $0.65 2/28/20238,550,000 shares $6.33 million -2.2%N/A15.5 $0.74 2/15/20238,740,000 shares $6.69 million -0.6%N/A15.9 $0.77 1/31/20238,790,000 shares $7.04 million -3.2%N/A15.6 $0.80 1/15/20239,080,000 shares $7.75 million -1.7%N/A15.5 $0.85 12/30/20229,240,000 shares $4.88 million -3.7%N/A18.1 $0.53 12/15/20229,590,000 shares $5.61 million -4.3%N/A21.2 $0.59 11/30/202210,020,000 shares $7.52 million -4.1%N/A22.4 $0.75 11/15/202210,450,000 shares $8.58 million -0.2%N/A23.7 $0.82 10/31/202210,470,000 shares $10.32 million -1.2%N/A19.5 $0.99 10/15/202210,600,000 shares $8.59 million -5.8%N/A19.2 $0.81 9/30/202211,250,000 shares $9.37 million -1.6%N/A18.9 $0.83 9/15/202211,430,000 shares $10.53 million -2.8%N/A11.8 $0.92 8/31/202211,760,000 shares $10.83 million -1.3%N/A10.1 $0.92 8/15/202211,910,000 shares $13.58 million -3.7%N/A9 $1.14 7/31/202212,370,000 shares $11.64 million -1.9%N/A8.9 $0.94 7/15/202212,610,000 shares $12.99 million -3.7%N/A7.9 $1.03 6/30/202213,100,000 shares $14.28 million -18.3%N/A7.5 $1.09 6/15/202216,040,000 shares $16.68 million -1.3%N/A8.7 $1.04 5/31/202216,250,000 shares $15.80 million -5.2%N/A9.4 $0.97 5/15/202217,140,000 shares $16.90 million -11.4%N/A9.4 $0.99 4/30/202219,350,000 shares $19.54 million +8.9%N/A9.6 $1.01 4/15/202217,770,000 shares $19.72 million +1.7%N/A8.7 $1.11 3/31/202217,480,000 shares $21.85 million -2.7%N/A8.4 $1.25 3/15/202217,960,000 shares $21.19 million +7.4%N/A7.5 $1.18 2/28/202216,720,000 shares $20.40 million -1.1%N/A6.6 $1.22 2/15/202216,910,000 shares $23.34 million +2.3%N/A6.4 $1.38 1/31/202216,530,000 shares $22.65 million -3.7%14.1%5.7 $1.37 1/15/202217,160,000 shares $25.05 million -0.8%N/A5.7 $1.46 12/31/202117,290,000 shares $27.66 million -3.8%N/A5.3 $1.60 12/15/202117,980,000 shares $35.42 million No ChangeN/A5.3 $1.97 11/30/202117,980,000 shares $40.81 million -3.1%N/A4.6 $2.27 11/15/202118,550,000 shares $47.67 million -3.3%N/A4 $2.57 10/29/202119,190,000 shares $49.32 million -8.5%N/A3.9 $2.57 10/15/202120,970,000 shares $59.97 million -5.9%N/A3.3 $2.86 9/30/202122,280,000 shares $72.63 million -5.9%N/A2.4 $3.26 9/15/202123,670,000 shares $78.82 million -3.8%N/A1.7 $3.33 8/31/202124,600,000 shares $93.48 million +3.9%N/A1.5 $3.80 8/13/202123,670,000 shares $76.22 million -24.3%N/A1.2 $3.22 7/30/202131,280,000 shares $93.53 million +21.6%N/A1.5 $2.99 7/15/202125,730,000 shares $144.60 million +25.3%21.3%1.2 $5.62 6/30/202120,530,000 shares $129.75 million +24.3%17.0%1.1 $6.32 6/15/202116,520,000 shares $76.32 million +20.0%13.7%1.1 $4.62 5/28/202113,770,000 shares $44.34 million +2.9%11.4%1 $3.22 5/14/202113,380,000 shares $31.58 million +0.7%N/A1.2 $2.36 4/30/202113,290,000 shares $30.83 million +26.7%N/A1.1 $2.32 4/15/202110,490,000 shares $19.51 million +4.5%N/A0.5 $1.86 3/31/202110,040,000 shares $20.58 million +52.4%N/A0.4 $2.05 3/15/20216,590,000 shares $19.18 million -6.7%N/A0.3 $2.91 2/26/20217,060,000 shares $20.54 million +22.6%N/A0.3 $2.91 2/12/20215,760,000 shares $18.37 million -37.4%N/A0.3 $3.19 1/29/20219,200,000 shares $19.14 million +9.0%N/A0.5 $2.08 1/15/20218,440,000 shares $10.55 million +1,172.4%N/A0.7 $1.25 12/31/2020663,300 shares $583.64 thousand -76.3%N/A0.1 $0.88 12/15/20202,800,000 shares $2.53 million +529.6%N/A1.2 $0.90 11/30/2020444,700 shares $773.78 thousand +53.1%N/A0.6 $1.74 11/15/2020290,400 shares $455.93 thousand +45.1%N/A1.2 $1.57 10/30/2020200,100 shares $310.16 thousand +15.9%N/A0.7 $1.55 10/15/2020172,700 shares $376.49 thousand -15.2%N/A0.4 $2.18 ATOS Short Interest - Frequently Asked Questions What is Atossa Genetics' current short interest? Short interest is the volume of Atossa Genetics shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 2,800,000 shares of ATOS short. Learn More on Atossa Genetics' current short interest. What is a good short interest ratio for Atossa Genetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATOS shares currently have a short interest ratio of 3.0. Learn More on Atossa Genetics's short interest ratio. Which institutional investors are shorting Atossa Genetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Atossa Genetics: Group One Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Atossa Genetics' short interest increasing or decreasing? Atossa Genetics saw a decrease in short interest in September. As of September 15th, there was short interest totaling 2,800,000 shares, a decrease of 21.6% from the previous total of 3,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Atossa Genetics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Atossa Genetics: Rapt Therapeutics (5.85%), Ocugen, Inc. (18.50%), Larimar Therapeutics, Inc. (9.24%), Alumis Inc. (3.53%), Autolus Therapeutics PLC Sponsored ADR (3.99%), Astria Therapeutics, Inc. (6.49%), ADC Therapeutics SA (3.62%), PureTech Health PLC Sponsored ADR (0.03%), 4D Molecular Therapeutics, Inc. (10.04%), Y-mAbs Therapeutics, Inc. (5.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Atossa Genetics stock? Short selling ATOS is an investing strategy that aims to generate trading profit from Atossa Genetics as its price is falling. ATOS shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Atossa Genetics? A short squeeze for Atossa Genetics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATOS, which in turn drives the price of the stock up even further. How often is Atossa Genetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATOS, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies Rapt Therapeutics Short Interest Ocugen Short Interest Larimar Therapeutics Short Interest Alumis Short Interest Autolus Therapeutics Short Interest Astria Therapeutics Short Interest ADC Therapeutics Short Interest PureTech Health Short Interest 4D Molecular Therapeutics Short Interest Y-mAbs Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATOS) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atossa Genetics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atossa Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
